Patent Yard Sign in
Expired European patentEurope

A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one

EP 1280804 B1 · Applicant: RPG Life Sciences Limited

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed May 5, 2000 and granted April 14, 2004. A European patent lasts at most 20 years from filing, so its term ended May 5, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by November 5, 2025.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMay 5, 2000
PublishedFebruary 5, 2003
GrantedApril 14, 2004
Term endedMay 5, 2020
Application numberEP 00940737
Classification (CPC)C07D471/04 +1 more

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedMay 5, 2000PublishedFeb 5, 2003Patent grantedApril 14, 2004Term endedMay 5, 2020

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.